Status:
UNKNOWN
Psycho-behavioral Intervention for Depression in Chronic Heart Failure
Lead Sponsor:
Peking University
Conditions:
Depression
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
The study aims to explore the effectiveness of psycho-behavioral intervention on depressive symptoms among older adults with chronic heart failure. Meanwhile, the effect on cardiac function and qualit...
Detailed Description
Depression has been one of the emerging health concerns for older adults, especially for those with chronic heart failure (CHF). It was about 4-5 times more prevalent among patients with CHF than heal...
Eligibility Criteria
Inclusion
- between 60 -85 years old.
- male or female.
- Diagnosis with depression as measured with PHQ-9 score of 5 and greater;
- The subject is diagnosed with chronic heart failure according to their history, symptoms, signs, and adjuvant examinations (eg,echocardiography), in line with the diagnostic criteria for chronic heart failure presented in the China Heart Failure Diagnosis and Treatment Guidelines, with NYHA (New York Heart Association) grade II-III.
- Reading and writing competency for completing the rating scales.
- Sufficient physical condition, hearing and vision to ensure the completion of psychological behavior intervention.
Exclusion
- Currently taking antidepressant drugs, and drug dose is unstable.
- With is a serious risk of suicide, suicide attempts and suicidal behavior (HAMD17 score of 30 or above, or suicide subscale score of 3 and above，or suicide subscale score of MINI of 6 or above).
- Intact cognitive function with CSI-D score of less than 7.
- Having other major mental disorders, including Alzheimer's disease, schizophrenia, schizoaffective psychiatric disorders, delusional disorders, undefined psychotic disorders, substance and alcohol abuse
- Planned heart surgery within 9 months.
- Unable to comply with psychological intervention due to serious physical conditions -
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT03233451
Start Date
August 1 2017
End Date
December 31 2020
Last Update
April 9 2019
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital, Capital Medical University
Beijing, China
2
Beijing Chaoyang Hospital, Capital Medical University
Beijing, China
3
Beijing Chaoyang Third Hospital
Beijing, China
4
Beijing Fengtai Tieying Hospital
Beijing, China